01/02/2005 - 21:00

Resonance passes FDA test

01/02/2005 - 21:00

Bookmark

Save articles for future reference.

A NON-INVASIVE test for iron overload disease developed by Western Australian biomedical company Resonance Health has received US Food and Drug Administration approval.The approval allows Resonance to market its FerriScan test in the US, where an estimated four million people are afflicted with iron

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options